Back to results
US 2022/0010018 A1Published application
MONOCLONAL ANTIBODIES AGAINST IgV DOMAIN OF B7-H3 AND USES THEREOF
AssigneeAlbert Einstein College of Medicine
InventorXingxing ZANG
Life of this patent
Estimating the term…
Abstract
The present disclosure provides monoclonal antibodies that bind to an IgV domain of human B7-H3. Also provided are methods of using these antibodies in treating cancer and infection and in imaging B7-H3 positive cells.
Claims20
An antibody or an antigen-binding fragment thereof that specifically binds to an IgV domain of a B7-H3 protein.
Dependencies are inferred from the claim text.